CPRX - カタリスト・ファ―マシュ―ティカルズ (Catalyst Pharmaceuticals Inc.)


   Why Is Catalyst (CPRX) Down 5.3% Since Last Earnings Report?  2019/12/12 16:30:19 Zacks Investment Research
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Catalyst Focuses on Firdapse Label Expansion Amid Competition  2019/11/29 08:39:00 Zacks Investment Research
Catalyst (CPRX) focuses on the development of Firdapse for additional indications.
   Catalyst Pharma (CPRX) to Post Q3 Earnings: What's in Store?  2019/10/29 08:46:00 Zacks Investment Research
During Catalyst's (CPRX) third-quarter 2019 conference call, investor focus will be on the sales performance of its only marketed drug Firdapse and its label expansion studies.
   Catalyst Pharmaceutical (CPRX) is a Great Momentum Stock: Should You Buy?  2019/09/13 14:00:06 Zacks Investment Research
Does Catalyst Pharmaceutical (CPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
   Implied Volatility Surging for Catalyst (CPRX) Stock Options  2019/09/13 12:41:00 Zacks Investment Research
Investors need to pay close attention to Catalyst (CPRX) stock based on the movements in the options market lately.
   Catalyst Pharma +3.4% as director buys 20,000 shares  2018-12-14
Catalyst Pharmaceuticals (NASDAQ: CPRX ) is up 3.4% postmarket, after the disclosure that director Charles O'Keeffe bought 20,000 shares today. More news on: Catalyst Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more …